Chief Financial Officer
Experienced biotech executive and finance leader.
Piers qualified as a Chartered Accountant in PwC’s London office before spending almost 10 years as an investment banker, focusing on Mergers, Acquisitions and Financings, initially at Close Brothers and later in Ernst & Young’s Lead Advisory practice.
In 2000 he joined Arrow Therapeutics (sold to Astra Zeneca for $150m) before working as CFO for a number of other biotech companies in UK, France, Netherlands, and Ireland. He has led IPOs on Nasdaq (uniQure: QURE and Verona: VRNA), as well as on AIM and Euronext Paris, and has raised more than $400m in new equity, convertibles, venture debt and strategic big-pharma investments. He has also been involved in numerous licensing transactions and the sale of Quethera to Astellas for £85m.
Piers holds an MA in Law and Management Studies from Cambridge University.